AORUI BIO
Aorui Bio is a biotech R&D company that combines whole genome liquid biopsy and ML tech for wireless cancer early screening technology.
AORUI BIO
Industry:
Biotechnology Medical
Founded:
2018-01-01
Address:
Hangzhou, Zhejiang, China
Country:
China
Website Url:
http://www.oriomics.com
Total Employee:
11+
Status:
Active
Contact:
+86 0571-28183061
Email Addresses:
[email protected]
Total Funding:
200 M CNY
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta LetsEncrypt HSTS Nginx Alibaba China Unicom
Similar Organizations
CuResponse
Curesponse is a medical company developing a three-dimensional tissue culture system for modeling cancer growth and drug response.
MabSpace Biosciences
MabSpace Biosciences is a biotech company focused on discovery & development of innovative antibody based therapeutics for cancer.
Pilot Biotechnology
Pilot Biotechnology is an industrial biotechnology company engaged in the development, production, and sales of health care products.
VLP Therapeutics
VLP is a biotech company with a mission to address unmet medical needs worldwide and expand the frontiers of vaccine treatment.
Investors List
Fortune Venture Capital
Fortune Venture Capital investment in Series B - Aorui Bio
Tao Capital
Tao Capital investment in Series B - Aorui Bio
Renjing Biology
Renjing Biology investment in Series B - Aorui Bio
Hotgen
Hotgen investment in Series B - Aorui Bio
Official Site Inspections
http://www.oriomics.com
- Host name: 118.31.229.149
- IP address: 118.31.229.149
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "Aorui Bio"
Aorui Bio - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +86 0571-28183061 Aorui Bio is a biotech R&D company that combines whole genome liquid biopsy and ML tech for wireless cancer early …See details»
翱锐生物|让每一个癌症患者诊断于早期
Oriomics-HRLB+ Oriomics-DLML克服了通过ctDNA进行癌症早期诊断所面临的巨大挑战。通过对ctDNA进行高度富集，对碎片化信息进行高效整合，对癌症信息进行全面覆盖，并基于大数据 …See details»
Oriomics Company Profile 2024: Valuation, Funding & Investors
Oriomics General Information Description. Developer of whole-genome liquid biopsy combined with machine learning for wireless early cancer screening technology. The company focuses …See details»
Oriomics - Products, Competitors, Financials, Employees, …
Oriomics specializes in the research and development, production, and sales of tumor in vitro diagnostic products. Use the CB Insights Platform to explore Oriomics's full profile. Oriomics - …See details»
Oriomics Secures Series B+ Funding to Advance Liver and …
Sep 11, 2023 Hangzhou-based Oriomics, a specialist in cancer screening based on circulating tumor DNA (ctDNA) methylation detection, has reportedly raised close to RMB 100 million (USD 13.7 million) in a Series B+ financing round. The round was led by Fortune Capital, with additional investments from Tao Capital, Hotgen Biotech, and the company's management team.See details»
Oriomics' Liver Cancer Screening Reagent Earns FDA Breakthrough …
Mar 24, 2025 Hangzhou-based Oriomics, a cancer screening specialist backed by Hotgen Biotech Co., Ltd (SHA: 688068), has obtained Breakthrough Device Designation (BDD) from …See details»
Hangzhou Aorui Biotechnology Co., Ltd. - Drug pipelines, Patents ...
Explore Hangzhou Aorui Biotechnology Co., Ltd. with its drug pipeline, therapeutic area, technology platform, .See details»
【首发】翱锐生物完成近亿元B轮融资，建设国内最全的消化道癌 …
Sep 11, 2023 动脉网获悉，近日，杭州翱锐生物科技有限公司（以下简称“翱锐生物”）完成近亿元b+轮融资，由达晨财智领投，道远资本、热景生物、以及公司管理团队跟投。本轮融资将主 …See details»
翱锐生物 | 项目信息-36氪
Jul 17, 2022 翱锐生物是杭州经济技术开发区政府引进的a类重点扶持高科技企业，专注于肿瘤无创早筛和癌症精准诊断。公司准确把握肿瘤精准治疗与全程管理的大趋势，通过持续的技术创新与优化，拓展肿瘤诊断全流程产品的研发、生产、销售和检测服务。依托强大的生物技术信息分析团队，采取无创液体 ...See details»
翱锐
人多基因甲基化、甲胎蛋白（afp）、甲胎蛋白异质体比率（afp-l3%）和异常凝血酶原（pivka-Ⅱ）联合检测分析软件See details»
翱锐生物（OriOmics）完成近亿元B轮融资 - 创投之家
Sep 11, 2023 杭州翱锐生物科技有限公司（翱锐生物，OriOmics）完成近亿元B+轮融资，由达晨财智领投，道远资本、热景生物、以及公司管理团队跟投。本轮融资将主要用于国内首个基 …See details»
翱锐生物-动脉网 - vbdata.cn
Jan 4, 2018 [email protected]. 翱锐生物自成立以来，深耕消化系统肿瘤无创早筛早诊的技术研发，致力于提供一流的消化系统肿瘤早筛产品。公司依托强大的生物技术和信息分析团 …See details»
翱锐生物科技有限公司
Oriomics-HRLB+ Oriomics-DLML克服了通过ctDNA进行癌症早期诊断所面临的巨大挑战。通过对ctDNA进行高度富集，对碎片化信息进行高效整合，对癌症信息进行全面覆盖，并基于大数据 …See details»
Oriomics Biotech Closes RMB 100 Million Series B Financing for …
Sep 11, 2023 杭州翱锐生物科技有限公司近日完成由达晨财智领投，道远资本、热景生物、以及公司管理团队跟投的近亿元b+轮融资，将主要用于中国首个基于pcr+蛋白的多组学平台的肝癌 …See details»
翱锐生物|让每一个癌症患者诊断于早期
扫描关注翱锐生物. 微信公众号. © © ORIOMICS 2020. All Rights Reserved ICP: 浙ICP备18028186号. loading……See details»
翱锐生物（OriOmics）完成近亿元B轮融资医药新闻-ByDrug-一站 …
⌈ByDrug医药新闻摘要⌋ 2023-09-11 00:00，微创投：杭州翱锐生物科技有限公司（翱锐生物，OriOmics）完成近亿元B+轮融资，由达晨财智领投，道远资本、热景生物、以及公司管理 …See details»
News_CAIVD & PCEM
The cooperation between Hotgen Biotech and Oriomics will jointly improve the layout of its multi-omics technology platform for early screening of cancer, whether in the development of liver …See details»
Oriomics Biotech Closes RMB 100 Million Series B Financing for …
Sep 11, 2023 China Hangzhou-based Oriomics Biotech closes approximately 100 million yuan ($13.6 million) Series B financing led by Furtune Capital and followed by Tao Capital, Hotgen …See details»
【首发】翱锐生物获热景生物过亿元战略融资，强强联合打造癌症 …
Jan 7, 2022 动脉网（微信：vcbeat）第一时间获悉，近日，杭州翱锐生物科技有限公司（以下简称“翱锐生物”）完成过亿元B轮融资，由著名的IVD上市公司热景生物战略投资，本轮融得资金 …See details»
翱锐生物：钱塘江畔的肿瘤甲基化筛查弄潮儿-动脉网
Nov 30, 2024 翱锐生物的技术优势不仅体现在其先进的甲基化检测技术上，还在于 公司自主研发的双层机器学习算法（Oriomics-DLML） ，该算法通过多层次的数据预处理和特征提取，能 …See details»